/news/b/articles/archive/2014/02/11/bind-rus-opens-new-r_2600_d-center-in-moscow.aspxBIND RUS, Russian pharmaceutical resident company of the Biomedical Cluster of Skolkovo Foundation, opened new R&D center on the territory of Technopark «Slava» on 6 February The company is a wholly owned subsidiary of BIND Therapeutics7.x Production